{
    "clinical_study": {
        "@rank": "144566", 
        "arm_group": [
            {
                "arm_group_label": "1. Eligible RCT/Elect RCT", 
                "description": "Eligible for regular chemotherapy, elects and receives regular chemotherapy"
            }, 
            {
                "arm_group_label": "2. Eligible RCT/Elect LDC", 
                "description": "Eligible for regular chemotherapy, elects and receives low-dose chemotherapy"
            }, 
            {
                "arm_group_label": "3. Eligible RCT/Elect PCO", 
                "description": "Eligible for regular chemotherapy, elects and receives palliative care only"
            }, 
            {
                "arm_group_label": "4. Ineligible RCT/Elect LDC", 
                "description": "Ineligible for regular chemotherapy, elects and receives low-dose chemotherapy"
            }, 
            {
                "arm_group_label": "5. Ineligible RCT/Elect PCO", 
                "description": "Ineligible for regular chemotherapy, elects and receives palliative care only"
            }
        ], 
        "brief_summary": {
            "textblock": "Patients diagnosed with Stage IV cancer (solid tumors only) are evaluated to determine\n      whether they are candidates for traditional chemotherapy.  If eligible, patients are offered\n      traditional chemotherapy, low-dose chemotherapy, or palliative care.  If ineligible,\n      patients are offered low-dose chemotherapy or palliative care.  Patients will be monitored\n      for 5 years and survival data recorded."
        }, 
        "brief_title": "Observational Study of Survival Outcomes of Stage IV Cancer Patients", 
        "completion_date": {
            "#text": "December 2018", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Stage IV Cancer (Solid Tumors Only)", 
            "Survival"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Presenting with Stage IV cancer (solid tumors only)\n\n        Exclusion Criteria:\n\n          -  Patient declines inclusion"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "primary care clinic"
            }
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01843985", 
            "org_study_id": "YLDZH-OS-1"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Stage IV cancer", 
            "Survival"
        ], 
        "lastchanged_date": "April 27, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Yang Ling", 
                    "country": "China", 
                    "state": "Shaanxi"
                }, 
                "name": "Yang Ling Demonstration Zone Hospital"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "5", 
        "official_title": "Observational Study of Survival Times of Stage IV Cancer Patients", 
        "overall_contact": {
            "email": "garylsmith2@msn.com", 
            "last_name": "gary smith", 
            "phone": "5207492035"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Institutional Review Board, Yang Ling Demonstration Zone Hospital", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "survival", 
            "safety_issue": "No", 
            "time_frame": "months 1, 2, 3, 4, 6, 9, 12, 18, 24, 36, 48, 60"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01843985"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Cure Cancer Worldwide Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cure Cancer Worldwide Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "N/A", 
        "study_type": "Observational", 
        "verification_date": "April 2013"
    }
}